Hereditary coagulopathies: Practical diagnosis and management for the plastic surgeon

Plastic and Reconstructive Surgery

Volumn 125, Issue 5, 2010, Pages 1544-1552

  Friedman, Tali ^b   O'Brien, Devin Coon ^b   Michaels V, Joseph ^b   Bontempo, Franklin ^b   Young, V Leroy ^b   Clavijo, Julio A ^b   Rubin, J Peter ^a  

^a Division of Plastic and Reconstructive Surgery   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ALGORITHM; ANTITHROMBIN III DEFICIENCY; ARTICLE; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLISM; MUTATION; PLASTIC SURGERY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHLEBITIS;

ACTIVATED PROTEIN C RESISTANCE; ALGORITHMS; ANTITHROMBIN III DEFICIENCY; BLOOD COAGULATION FACTORS; FACTOR V; HUMANS; HYPERHOMOCYSTEINEMIA; MUTATION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; SURGERY, PLASTIC; THROMBOPHLEBITIS;

EID: 77951798542     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181d51344     Document Type: Article

References (61)

1. Schafer AI, Levine MN, Konkle BA, Kearon C. Thrombotic disorders: Diagnostics and treatment. Hematology Am Soc Hematol Educ Program 2003;520-539.
2. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008;112:19-27.
3. Anderson FA Jr, Wheeler HB. Venous thromboembolism: Risk factors and prophylaxis. Clin Chest Med. 1995;16:235-251.
4. Hirsh H, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Councilon Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996;93:2212-2245.
5. Geerts WH, PineoG,BergqvistD,et al. Prevention of venous thromboembolism: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126 (3 Suppl.):338s-400s. (Pubitemid 39302602)
6. Anderson FA, Wheeler HB, Goldenberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992; 152:1660-1664.
7. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446-455. (Pubitemid 37138770)
8. Kfoury E, Taher A, Saggieh S, Otrock CK, Mahfouz R. The impact of inherited thrombophilia on surgery: A factor to consider before transplantation? Mol Biol Rep. 2009;36:1041-1051.
9. Weitz J, Middeldorp S, Geerts W, Heit JA. Thrombophilia and new anticoagulant drugs. Hematology 2004;20:424-438.
10. Middeldrop S, Levi M. Thrombophilia: An update. Semin Thromb Hemost. 2007;33:563-572. (Pubitemid 47429308)
11. Cohn DM, Roshani S, Middeldorp S. Thrombophilia and venous thromboembolism: Implications for testing. Semin Thromb Hemost. 2007;33:573-581. (Pubitemid 47429309)
12. van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects. Arch Intern Med. 2007;167:282-289. (Pubitemid 46889789)
13. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S. (Pubitemid 351894916)
14. Metcalfe SA, Barlow-StewartK,CampbellJ,Emery J. Genetics and blood: Haemoglobinopathies and clotting disorders. Aust Fam Physician 2007;36:812-819.
15. Simioni P, Tormene D, Spiezia L, et al. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost. 2006;32:700-708. (Pubitemid 44623377)
16. Lonn E, Yusef F, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;13:1567-1577.
17. Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia? Am J Med. 2008;121:458-463. (Pubitemid 351694352)
18. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant factor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994; 91:1396-1400. (Pubitemid 24059018)
19. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med. 2006;166:729-736.
20. Straczek C, Oger E, Jonage-Canonico MB, et al. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration. Circulation 2005;112:3495-3500. (Pubitemid 43739566)
21. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA. 2006;296:397-402. (Pubitemid 44127523)
22. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134.
23. Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210a mutation: A systematic review of prospective studies. Hematologica 2007;92:1107-1114. (Pubitemid 350144218)
24. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
25. Deitcher SR, Gomes MCP. Hypercoagulable States: Disease Management Project. Cleveland, Ohio: The Cleveland Clinic Foundation; 2003.
26. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345:152-155.
27. van Hylckama Vlig A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of coagulation factor XI increase the risk of venous thrombosis. Blood 2000;95:3678-3682. (Pubitemid 30412836)
28. Meijers JC, Tekelenburgh WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696-701. (Pubitemid 30131422)
29. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis: A case-control study of plasma levels and DNA polymorphisms. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1994;71:719-722.
30. Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5-9. (Pubitemid 30045467)
31. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994; 87:106-112. (Pubitemid 24207007)
32. Heijboer H, Brandjes DP, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 1990;323:1512-1516.
33. Koster T, Rosendaal FR, Briet E, et al. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995;85:2756-2761.
34. Monagle P, Andrew M, Halton J, et al. Homozygous protein C deficiency: Description of a new mutation and successful treatment with low molecular weight heparin. Thromb Haemost. 1998;79:756-761. (Pubitemid 28163850)
35. Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: Influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001;113:636-641.
36. Hackeng TM, van't Veer C, Meijers JC, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factor Va and Xa. J Biol Chem. 1994;269:21051-21058.
37. Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost. 1990;16:299-309.
38. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta synthase deficiency. Am J Hum Genet. 1985;37:1-31. (Pubitemid 15138674)
39. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
40. Der Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3:292-299. (Pubitemid 41623617)
41. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep thrombosis. Ann Intern Med. 1996; 125:1-7. (Pubitemid 126505333)
42. Schafer AI. Venous thrombosis as a chronic disease. N Engl J Med. 1999;340:955-956.
43. Meltzer ME, Doggen CJ, de Groot PG, Rosendaal FR, Lisman T. Fibrinolysis and the risk of venous thrombosis. Curr Opin Hematol. 2007;14:242-248.
44. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101:1827-1832. (Pubitemid 36237580)
45. Gezer S. Antiphospholipid syndrome. Dis Mon. 2003;49: 696-741. (Pubitemid 38018104)
46. Marchiori A, Mosena L, Prandoni P. Superficial vein thrombosis: Risk factors, diagnosis and treatment. Semin Thromb Hemost. 2006;32:737-743. (Pubitemid 44623382)
47. Roberts LN, Patel RK, Arya R. Venous thromboembolism and ethnicity. Br J Haematol. 2009;146:369-383.
48. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res. 1997;87:377-385. (Pubitemid 27381882)
49. Grazer FM, Goldwyn RM. Abdominoplasty assessed bysurvey, with emphasis on complications. Plast Reconstr Surg. 1977; 59:513-517.
50. Matarasso A, Swift RW, Rankin M. Abdominoplasty and abdominal contour surgery: A national plastic surgery survey. Plast Reconstr Surg. 2006;117:1797-1808. (Pubitemid 44324363)
51. Neaman KC, Hansen JE. Analysis of complications from abdominoplasty: A review of 206 cases at a university hospital. Ann Plast Surg. 2007;58:292-298. (Pubitemid 46667876)
52. Shermak MA, Chang DC, Heller J. Factors implicating thromboembolism after bariatric body contouring surgery. Plast Reconstr Surg. 2007;119:1590-1596; discussion 1597-1598. (Pubitemid 46559129)
53. Teimourian B, Rogers WB III. A national survey of complications associated with suction lipectomy: A comparative study. Plast Reconstr Surg. 1989;84:628-631. (Pubitemid 19249825)
54. Seruya M, Baker SB. MOC-PS(SM) CME article: Venous thromboembolism prophylaxis in plastic surgery patients. Plast Reconstr Surg. 2008;122 (3 Suppl):1-9.
55. Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: Systematic review and costeffectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006;10:1-110.
56. O'Brien SH, Smith KJ. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective. J Pediatr. 2009;155:100-104.
57. Jackson BR, Holmes K, Phansalkar A, Rodgers GM. Testing for hereditary thrombophilia: A retrospective analysis of testing referred to a national laboratory. BMC Clin Pathol. 2008;8:3. (Pubitemid 351579664)
58. Kakkos SK, Caprini JA, Geroulakos G,Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev. 2008;4: CD005258.
59. Comerota AJ, Chouhan V, Harada RN, et al. The fibrinolytic effects of intermittent pneumatic compression: Mechanism of enhanced fibrinolysis. Ann Surg. 1997;226:306-313; discussion 313-314. (Pubitemid 28070923)
60. Killewich LA, Cahan MA, Hanna DJ, et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg. 2002;36:953-958.
61. Broughton G II, Rios JL, Rohrich RJ, Brown SA. Deep venous thrombosis prophylaxis practice and treatment strategies among plastic surgeons: Survey results. Plast Reconstr Surg. 2007;119:157-174. (Pubitemid 46360260)